טוען...

Epigenetic Therapies in MDS and AML

The use of low dose hypomethylating agents for patients with myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia (AML) has had made a significant impact. In the past, therapies for these diseases were limited and patients who elected to receive treatment were subject to highly toxic,...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Griffiths, Elizabeth A., Gore, Steven D.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2013
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4086806/
https://ncbi.nlm.nih.gov/pubmed/22956506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/978-1-4419-9967-2_13
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!